SCHEMBL30745641

SCHEMBL30745641

CCOC(=O)c1ccc2c(c1)nc(Cl)c1[nH]c3ccncc3c12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKN1 Q16512 1/20 0.47
PKN2 Q16513 1/20 0.47
IMPDH2 P12268 1/20 0.44
SIRT2 Q8IXJ6 2/20 0.44
SIRT1 Q96EB6 1/20 0.44
SIRT3 Q9NTG7 1/20 0.44
HCRTR1 O43613 2/20 0.43
ALDH1A1 P00352 5/20 0.42
KDM4E B2RXH2 4/20 0.42
MEN1 O00255 2/20 0.42
RAB9A P51151 2/20 0.42
KMT2A Q03164 2/20 0.42
MAPT P10636 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CSNK2A1 P68400 4/20 0.42
CSNK2A2 P19784 4/20 0.42
CSNK2B P67870 4/20 0.42
HPGD P15428 2/20 0.42
HSD17B10 Q99714 2/20 0.42
POLB P06746 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30686842 0.77 ALDH1A1 (0.59) PKN1PKN2IMPDH2SIRT2SIRT1
SCHEMBL30724459 0.76 ALDH1A1 (0.45) IMPDH2SIRT2SIRT1SIRT3ALDH1A1
SCHEMBL30824330 0.75 KDM4E (0.50) PKN1PKN2IMPDH2HCRTR1ALDH1A1
SCHEMBL30815988 0.75 MMP13 (0.47) PKN1PKN2ALDH1A1KDM4EMEN1
SCHEMBL30802436 0.74 CDK1 (0.50) PKN1PKN2SIRT2SIRT1SIRT3
SCHEMBL30885770 0.73 ALDH1A1 (0.48) PKN1PKN2IMPDH2SIRT2SIRT1
SCHEMBL30833239 0.72 MMP13 (0.47) PKN1PKN2ALDH1A1KDM4EMEN1
SCHEMBL30776676 0.72 CDK1 (0.48) PKN1PKN2ALDH1A1KDM4EMEN1
SCHEMBL30776675 0.72 CDK1 (0.48) PKN1PKN2ALDH1A1KDM4EMEN1
SCHEMBL26976050 0.72 MMP13 (0.47) PKN1PKN2ALDH1A1KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11884668-B1 Substituted pyrido[3′,4′:4,5]pyrrolo[2,3-c]quinolines as CK2 inhibitors King Faisal University (SA) 2024-01-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11884668-B1 Substituted pyrido[3′,4′:4,5]pyrrolo[2,3-c]quinolines as CK2 inhibitors CSNK1A1L, CCNL2, CDKL3 PKN1 324/4885PKN2 97/4885IMPDH2 2441/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.